Article Sidebar
Views PDF: 0
MAJOR LIVER RESECTION, EXTRAHEPATIC DUCT RESECTION AND COMBINED WITH VASCULAR RESECTION IN SURGICAL TREATMENT FOR PERIHILAR CHOLANGIOCARCINOMA INVASED TO VESSELS
Main Article Content
Abstract
Objective: to report the results after surgery for peri hilar cholangiocarcinoma with vascular invasion. Methods: Retrospective study from June 2022 to June 2023 of cases of peri hilar cholangiocarcinoma with vascular invasion undergoing major hepatectomy, extrahepatic bile duct resection, and vascular resection at the organ transplant center of Viet Duc hospital. Results: There were 2 patients with perihilar cholangiocarcinoma with vascular invasion: patient 1 was diagnosed with type 3a perihilar cholangiocarcinoma and underwent right liver and segment 1 resection, extrahepatic bile duct resection with portal vein resection, anatomosed main porta vein with left porta vein.. Patient 2 was diagnosed with type 3b perihilar cholangiocarcinoma and had the left hepatectomy, extrahepatic bile duct resection, portal vein resection and anatomosed the main portal vein with the right portal vein and hepatic artery resection then anatomosed the right hepatic artery with gastroduodenal artery. Postoperative status of both patients was stable, with no postoperative complications. Currently, patient 1 is 1.5 years after surgery and patient 2 is 1 year after surgery, stable and has no recurrence after surgery. Conclusion: Perihilar cholangiocarcinoma with vascular invasion can be safely performed and achieved radical surgery and initially encouraging results after surgery.
Article Details
Keywords
perihilar cholangiocarcinoma, major liver resection, hepatic vascular resection
References
2. Jeroen L. A. van Vugt et al., “The Prognostic Value of Portal Vein and Hepatic Artery Involvement in Patients with Perihilar Cholangiocarcinoma,” HPB 20, no. 1 (January 1, 2018): 83–92, https://doi.org/10.1016/j.hpb. 2017.08.025.
3. T Sugiura et al., “Major Hepatectomy with Combined Vascular Resection for Perihilar Cholangiocarcinoma,” BJS Open 5, no. 4 (August 5, 2021): zrab064, https://doi.org/10.1093/ bjsopen/zrab064.
4. Gerald Klatskin, “Adenocarcinoma of the Hepatic Duct at Its Bifurcation within the Porta Hepatis,” The American Journal of Medicine 38, no. 2 (February 1965): 241–56, https://doi.org/ 10.1016/0002-9343(65)90178-6.
5. A Nakeeb et al., “Cholangiocarcinoma. A Spectrum of Intrahepatic, Perihilar, and Distal Tumors.,” Annals of Surgery 224, no. 4 (October 1996): 463–75.
6. T Ebata et al., “Proposal to Modify the International Union Against Cancer Staging System for Perihilar Cholangiocarcinomas,” British Journal of Surgery 101, no. 2 (December 23, 2013): 79–88, https://doi.org/10.1002/bjs.9379.
7. Takehiro Noji et al., “Concomitant Hepatic Artery Resection for Advanced Perihilar Cholangiocarcinoma: A Narrative Review,” Cancers 14, no. 11 (May 27, 2022): 2672, https://doi.org/10.3390/cancers14112672.
8. Hiroshi Shimada et al., “Hepatic Resection Combined with Portal Vein or Hepatic Artery Reconstruction for Advanced Carcinoma of the Hilar Bile Duct and Gallbladder,” World Journal of Surgery 27, no. 10 (October 2003): 1137–42, https://doi.org/10.1007/s00268-003-6801-6.